CovClear COVID-19 Rapid Antigen Test

The CovClear Rapid Antigen test is a lateral flow assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasal swab specimens directly collected.


Out of stock


Why CovClear?

The Safety Seal cap on the CovClear unit permanently contains all bio-exposed test components. Tamper-proof design locks in results with 100% identification certainty. Buffer quantity calibrated for absorbent pad – no excess liquid media.



  • Failure to follow the instructions for use may adversely affect test performance and/or invalidate the test result.
  • Results from antigen testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2
    infection or to determine infection status.
  • The detection of SARS-CoV-2 nucleocapsid antigen is dependent upon proper specimen collection, handling, storage, and preparation. Failure to observe proper procedures in any one of these steps can lead to incorrect results.
  • Results from the device should be correlated with the clinical history, epidemiological data and other data available.
  • False-negative results may occur if the concentration of the target antigen in the clinical specimen is below the detection limits of the device.
  • There is a higher chance of false negative results with home use tests than with laboratory-based molecular tests. This means that there is a higher chance this test will give you a negative result when you have COVID-19.
  • The performance of this device has not been assessed in a population vaccinated against COVID-19.